These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 21334859

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G, Bobes J, Cervera G, Terán A, Pérez M, López-Gómez V, Rejas J.
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ, Mandel FS, Schweizer E.
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series.
    Oulis P, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kouzoupis AV, Konstantakopoulos G, Soldatos CR.
    Int Clin Psychopharmacol; 2008 Mar; 23(2):110-2. PubMed ID: 18301126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of pregabalin in alcohol dependence.
    Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P.
    Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
    [Abstract] [Full Text] [Related]

  • 13. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G.
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM, Powe KW, Cates ME.
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [Abstract] [Full Text] [Related]

  • 16. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A, Hein J, Volkmar K, Winter M, Richter C, Heinz A, Müller CA.
    Alcohol Alcohol; 2012 Dec; 47(2):149-55. PubMed ID: 22215002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.